Navigation Links
CryoLife Signs Definitive Agreement to Acquire Cardiogenesis
Date:3/29/2011

oduct.  There is no guarantee that the FDA will approve PerClot for distribution in the U.S. by the end of 2013, if at all.  FDA approvals are dependent upon a number of factors, many of which are outside CryoLife’s control, including successful clinical trial results, and discretionary decisions made by the FDA personnel.  Any number of factors could delay clinical trial conduct and analysis and result in delays in the approval process.  Risks and uncertainties related to the transaction with Cardiogenesis also include uncertainties as to the timing of the tender offer and merger, uncertainties as to how many of the Cardiogenesis shareholders will tender their stock in the offer, the risk that competing offers will be made, the possibility that various closing conditions for the transaction may not be satisfied or waived, including that a governmental entity may prohibit or delay the transaction, and the effects of disruption from the transaction making it more difficult to maintain relationships with employees, customers, business partners or governmental entities.  Furthermore, CryoLife’s ability to fully realize the anticipated benefits of the transaction with Cardiogenesis may be materially adversely impacted if the integration of Cardiogenesis’ business with CryoLife is slower than expected or unsuccessful, or if the transaction and subsequent efforts to integrate Cardiogenesis’s business with CryoLife distracts CryoLife’s management team from the other facets of CryoLife’s business.  Also, estimates regarding the anticipated markets addressed by Cardiogenesis products may not prove to be accurate, as the assumptions are based on a variety of inputs beyond the control of CryoLife, including anticipated cardiac patient populations, and market demand for Cardiogenesis products is subject to the changing preferences of physicians and patients and will be influenced by various economic indicators. &
'/>"/>
SOURCE CryoLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
2. CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R)
3. CryoLife Reports Record Quarterly Revenues of $28.2 Million
4. CryoLife to Present at Upcoming Investor Conferences in New York
5. CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference
6. CryoLife Provides Initial 2010 Financial Guidance
7. CryoLife Enters into Worldwide Distribution and Manufacturing Agreements with Starch Medical for Novel Hemostatic Agent
8. CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive
9. CryoLife Announces Release Date and Teleconference Call Details for 2010 Third Quarter Financial Results
10. CryoLife Begins Distribution of Blood-Clotting Agent PerClot® in Europe
11. CryoLife to Present at Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... ) has announced the addition of the  ... Testing Market"  report to their offering.  ... ,This comprehensive report is designed to help ... and evaluate business opportunities emerging in the ...
(Date:5/27/2015)... 2015   Madison Laser Tattoo Removal is the ... and the surrounding area to offer treatments with ... Tattoo Removal is dedicated to bringing a solution to those ... . "I founded Madison Laser Tattoo Removal to ... their skin to its natural look," said Emily Livesey, ...
(Date:5/27/2015)... 2015 OpportunityAnalyzer: Cushing,s Syndrome - Opportunity ... GlobalData estimates that the 2013 sales for the ... across the 6MM covered in this report. Pharmaceutical ... time, and financial resources in the CS field, ... (R&D) strategies. One notable example is the fact ...
Breaking Medicine Technology:United States Hemostasis Diagnostic Testing Market Strategies 2015 2Madison Laser Tattoo Removal Brings Superior Laser Tattoo Removal Services To Madison, WI With Astanza Duality 2OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 2OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 3OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 4
... , ROCKVILLE, Md. , ... today new data from a clinical study that began in May ... with Novavax,s trivalent seasonal influenza Virus-like Particle (VLP) vaccine. The vaccine ... H1N1 A/ Brisbane /59/2007, H3N2 A/ Brisbane /10/2007, and B/ Florida ...
... , , Inadequacies May Contribute ... 8 The first results from a large-scale study of ... high percentage of medicines circulating on national markets are of substandard ... of Plasmodium falciparum , the most virulent form of malaria. ...
Cached Medicine Technology:NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults 2NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults 3NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults 4One-Third of Antimalarial Medicines Sampled in Three African Nations Found to Be Substandard in Large-Scale USP-WHO Study 2One-Third of Antimalarial Medicines Sampled in Three African Nations Found to Be Substandard in Large-Scale USP-WHO Study 3One-Third of Antimalarial Medicines Sampled in Three African Nations Found to Be Substandard in Large-Scale USP-WHO Study 4One-Third of Antimalarial Medicines Sampled in Three African Nations Found to Be Substandard in Large-Scale USP-WHO Study 5
(Date:5/27/2015)... Clearwater, Florida (PRWEB) May 27, 2015 ... accurate, impartial customer satisfaction surveys in the multiple ... user poll to determine the highest ranked Electronic ... As part of a special research focus on ... and announced those software vendors with the highest ...
(Date:5/27/2015)... 27, 2015 The MedSpa at Hendrick ... dermal filler treatments in Abilene, Texas: Xeomin®, Belotero Balance® ... appearance of glabellar lines, better known as the lines ... is designed to treat smoker’s lines around the mouth ... while Radiesse® improves the appearance of smile lines or ...
(Date:5/27/2015)... 27, 2015 Coco Libre announced today that ... to reach for Organic Coconut Water to quench their thirst ... available at VIP areas, artist greenrooms, corporate skyboxes and concessions ... area hotels and on festival shuttle buses. , “We’re ... said Noa Elan, Director of Strategic Partnerships for Latitude 38 ...
(Date:5/27/2015)... Genius Monkey is pleased to announce ... technology, they have boosted sales for the Utah Honda ... level for seven Utah-based dealers. , Until recently, ... radio media. In 2014 the Utah Honda dealers changed ... Genius Monkey , shifted their marketing campaigns more towards ...
(Date:5/27/2015)... With a prevalently high rate of ... the "ACA - Controlling the Chaos" webinar revealed that, ... in the process of researching ACA solution options ... for the reporting mandates. , According to a sample ... who are currently vetting ACA reporting solutions are on ...
Breaking Medicine News(10 mins):Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2
... personal changes and changes in relationships one year after their ... are not universal. These are the findings from the first ... to examine changes in siblings after the death of ... mothers, fathers and siblings. Nearly 60,000 children under the ...
... breast cancers are due to mutations in genes called BRCA1 ... these genes greatly increases the risk of cancer is not ... the online, open-access journal PLoS Biology , an international ... Institute (IDIBELL) and the Catalan Institute of Oncology (ICO), and ...
... 30 percent the nation,s state police agencies reported that ... of those, nearly 60 percent of said only a ... board, according to new research from the Perelman School ... be presented today at the American Heart Association,s annual ...
... Randy Dotinga HealthDay Reporter , TUESDAY, Nov. 15 ... doesn,t appear to improve the bone health of postmenopausal ... The treatment -- which involves standing on a motorized, vibrating ... promise in animals. But researchers, who hoped those results might ...
... test was found to be more effective for ruling ... than myocardial perfusion imaging (MPI), a common test that ... and function of the heart., Study results were presented ... conference in Orlando, Fla. , "In this real-world patient ...
... health classes fail to help students refuse sexual advances or ... knowledge, a new study reveals. But when teachers emphasized ... health, students had much better responses. In these kinds of ... better able to navigate sexual situations. "A focus on ...
Cached Medicine News:Health News:Children experience differing changes one year after a sibling's death from cancer 2Health News:A new molecular mechanism in breast cancer development 2Health News:Whole-Body Vibration Doesn't Build Bone After All: Study 2Health News:Blood-based genomic test better than imaging test for ruling out obstructive coronary artery disease 2Health News:Focus on testing hurts students in high school health classes 2Health News:Focus on testing hurts students in high school health classes 3
... The Series I Instrument program offers ... low profile, while maintaining strength and durability. ... pathology in tight joint spaces. Series I ... cutting tip style, size and angle required ...
... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ... angle required for large and small joint ...
... The Series I Instrument program offers ... low profile, while maintaining strength and durability. ... pathology in tight joint spaces. Series I ... cutting tip style, size and angle required ...
... facilitates fast and effective resection of meniscal ... meniscal rim. The flat, crescent-shaped tip has ... the tightest joint spaces. Made in the ... of engineering experience in arthroscopy hand instrument ...
Medicine Products: